Neurones (XPAR:NRO) Total Liabilities: €284.2 Mil (As of Dec. 2025)

What is Neurones Total Liabilities?

Neurones XPAR:NRO -1.82% 96 Total Liabilities is €284.2 Mil as of Dec. 2025. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.30 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Neurones's Total Liabilities for the quarter that ended in Dec. 2025 was €284.2 Mil.

Neurones's quarterly Total Liabilities declined from Dec. 2024 (€289.52 Mil) to Jun. 2025 (€286.04 Mil) and declined from Jun. 2025 (€286.04 Mil) to Dec. 2025 (€284.16 Mil).

Neurones's annual Total Liabilities increased from Dec. 2023 (€266.34 Mil) to Dec. 2024 (€289.52 Mil) but then declined from Dec. 2024 (€289.52 Mil) to Dec. 2025 (€284.16 Mil).

Neurones Total Liabilities Related Terms

Neurones Total Liabilities Historical Data

* Premium members only.

The historical data trend for Neurones's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurones Total Liabilities Chart

Neurones Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

214.90

240.64

266.34

289.52

284.16

Neurones Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Liabilities	Get a 7-Day Free Trial															266.34	280.50	289.52	286.04	284.16

96GF Score

Neurones XPAR:NRO

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Neurones Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Neurones's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	250.055	+	(26.019	+	5.3290705182008E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	8.089	+	0)
	=	284.2

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	749.032	-	464.869
	=	284.2

Neurones's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	250.055	+	(26.019	+	5.3290705182008E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	8.089	+	0)
	=	284.2

Total Liabilities	=	Total Assets (Q: Dec. 2025 )	-	Total Equity (Q: Dec. 2025 )
	=	749.032	-	464.869
	=	284.2

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of €284.2 Mil mean?

Neurones (XPAR:NRO) has a Total Liabilities of €284.2 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Neurones and its competitors.

Is Neurones' Total Liabilities too high?

Neurones' current Total Liabilities is €284.2 Mil. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Neurones' Total Liabilities compare to IBM and ACN?

Neurones' Total Liabilities of €284.2 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Software company?

A good Total Liabilities depends on the Software industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Neurones and its competitors. Neurones's current Total Liabilities is €284.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Neurones stock overvalued right now?

Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.30, compared to a current price of €35.00 — trading 30.4% below its estimated fair value. The current Total Liabilities is €284.2 Mil. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Total Liabilities is €284.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €35.00 is trading 30.4% below its estimated GF Value™ of €50.30. GuruFocus considers Neurones to be Significantly Undervalued.

Key valuation signals for XPAR:NRO:

Total Liabilities: €284.2 Mil
GF Value™: €50.30 vs. price of €35.00 (30.4% below fair value)
GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neurones Business Description

Industry Technology Software

Comparable Companies XPAR:AUB XPAR:WAVE XPAR:ATO XPAR:INF XPAR:MLCHE XPAR:ALKEY XPAR:S30 XPAR:ALITL XPAR:ALHIT XPAR:FPG IBM NSE:TCS ACN NSE:INFY TSE:6702 TSE:6701 NSE:HCLTECH FISV XMAD:AMS FIS

Other Exchanges 0GX2:UK NE9:Germany

Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024

Website https://www.neurones.net

Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.

96GF Score

Get the complete analysis for XPAR:NRO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.00

Price

€50.30

GF Value

View XPAR:NRO Analysis

See Total Liabilities data for all stocks →